The 71 DKTK Munich Cancer Colloquium will be held on March 23, 2026. 

Agenda

• Leveraging real-world data for knowledge generation in patients receiving T-cell based immunotherapies
  PD Dr. med. Kai Rejeski, MHBA
  Group Leader Precision Immunotherapy, Department of Internal Medicine III, LMU Klinikum
• Uncovering orchestrators of immunosuppression in pancreatic cancer using spatial functional genomics
  Chiara Falcomatà, PhD
  Postdoctoral fellow at Brown Lab at Icahn School of Medicine at Mount Sinai; New York, USA
• DKTK News
  Prof. Michael von Bergwelt, Spokesperson DKTK partner site Munich

Zoom-Meeting ID: 618 5229 2497 / Kenncode: DKTK71MCC
https://dkfz-de.zoom-x.de/j/61852292497?pwd=QbCawiLv7aqId9t1wFQxyhzoa4bb6s.1

key words: immunotherapy, gastrology, genomics